feed,title,long_url,short_url
SeekingAlpha,Rhythm Pharmaceuticals reports mixed Q4 results; initiates FY24 outlook,https://seekingalpha.com/news/4070204,
SeekingAlpha,"N-able Non-GAAP EPS of $0.11 beats by $0.03, revenue of $108.4M beats by $1.35M",https://seekingalpha.com/news/4070203,
SeekingAlpha,"Newmont Non-GAAP EPS of $0.50, revenue of $4B",https://seekingalpha.com/news/4070202,
SeekingAlpha,Gannett misses top-line and bottom-line estimates; initiates FY24 and beyond outlook,https://seekingalpha.com/news/4070201,
